RxDoctor Payments DataLook up a doctor →

Philip Rosenblum, MD

Family Medicine · Thornton, CONPI 1295732022

Payments from drug & device makers

$17,687in general payments, 2019–2025

Across 1,030 payments — averaging $17.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • AstraZeneca$2K
  • Novo Nordisk$2K
  • Boehringer Ingelheim$1K
  • Lilly USA, LLC$1K
  • Pfizer$1K
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$17,670100%
  • Education$170%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)195$3,313
AstraZeneca(2 entities)119$2,315
Novo Nordisk105$1,681
Boehringer Ingelheim93$1,432
Lilly USA, LLC85$1,110
Pfizer74$1,036
GSK45$871
Bayer23$499
Johnson & Johnson34$492
Medtronic(3 entities)15$462
Amgen(2 entities)22$404
Abbott24$363
Novartis21$355
Merck20$301
Sanofi-aventis U.S. LLC13$252
Biohaven Pharmaceutical Holding Company Ltd.10$216
Biohaven Pharmaceuticals, Inc.10$152
Otsuka America Pharmaceutical, Inc.8$147
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC8$127
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$112
Grifols USA, LLC4$110
Amarin Pharma, Inc.5$106
Axsome Therapeutics, Inc.2$87
Astellas Pharma US Inc4$84
Eisai Inc.4$82
Vanda Pharmaceuticals Inc.3$82
Cranial Technologies, Inc5$71
Dexcom, Inc.3$64
Hologic Sales And Service, LLC3$63
Takeda Pharmaceuticals U.S.A., Inc.3$61
Edwards Lifesciences2$55
Si-bone, Inc.3$55
IBSA Pharma Inc.3$47
Genentech USA, Inc.2$47
Ironwood Pharmaceuticals, Inc3$44
Corium, LLC3$43
Idorsia Pharmaceuticals US Inc3$42
Boston Scientific2$41
Biogen2$41
Cleerly, Inc.1$38
Gilead2$37
Philips North America LLC1$35
Jazz Pharmaceuticals Inc.2$34
Exact Sciences1$28
Currax Pharmaceuticals LLC2$28
Seqirus USA Inc1$28
Coopersurgical, Inc.2$26
Esperion Therapeutics, Inc.1$24
E.r. Squibb & Sons, L.L.C.1$23
Abiomed1$23
ANI Pharmaceuticals, Inc.1$23
Phadia US Inc.1$23
Optinose US, Inc.1$23
Baxter Healthcare1$23
VBI Vaccine (delaware) Inc.1$22
Phathom Pharmaceuticals, Inc.1$21
Organon1$21
Corcept Therapeutics1$21
Lundbeck LLC1$21
Inspire Medical Systems, Inc.1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,687 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$59,904
Medicare patients
150
Services billed
787

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xigduo XrDapaglifloz Propaned/Metformin97$127,264
Synjardy XrEmpagliflozin/Metformin Hcl76$108,146
EliquisApixaban93$107,628
OzempicSemaglutide86$96,607
XareltoRivaroxaban59$83,126
TrulicityDulaglutide48$76,415
FarxigaDapagliflozin Propanediol49$63,958
JardianceEmpagliflozin26$45,122
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$36,391
MounjaroTirzepatide34$36,188
Breztri AerosphereBudesonide/Glycopyr/Formoterol28$34,794
Tresiba Flextouch U-200Insulin Degludec21$30,607
Repatha SureclickEvolocumab27$24,166
Tresiba Flextouch U-100Insulin Degludec25$16,679
EntrestoSacubitril/Valsartan12$15,466

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimSynjardy Xr, Jardiance, Stiolto Respimat$1,432$163,934120 claims
Lilly USA, LLCTrulicity, Mounjaro$1,110$112,60382 claims
Novo NordiskOzempic, Wegovy$1,681$112,01997 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$2,315$109,40797 claims
PfizerEliquis$1,036$107,62893 claims
Johnson & JohnsonXarelto$492$83,12659 claims
GSKTrelegy Ellipta$871$36,39136 claims
NovartisEntresto$355$15,46612 claims
MerckJanuvia$301$14,54413 claims
Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus$252$14,39524 claims
ANI Pharmaceuticals, Inc.Valsartan$23$1,60493 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Thornton

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →